The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers

PURPOSE: Concomitant treatment with the glucose-lowering drug metformin and the platelet aggregation inhibitor dipyridamole often occurs in patients with type 2 diabetes mellitus who have suffered a cerebrovascular event. The gastrointestinal uptake of metformin is mediated by the human equilibrativ...

Descripción completa

Detalles Bibliográficos
Autores principales: El Messaoudi, S., Russel, F. G., Colbers, A., Bandell, C. C. J. G., van den Broek, P. H. H., Burger, D. M., Rongen, G. A., Riksen, N. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Pharmacokinetics and Disposition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869751/
https://www.ncbi.nlm.nih.gov/pubmed/26979520
http://dx.doi.org/10.1007/s00228-016-2039-8

Ejemplares similares

Ejemplares similares